Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Aurobindo Pharma Gets FDA Approval for Naproxen Painkiller Pill

Nov. 2 (Bloomberg) -- Aurobindo Pharma Ltd., an Indian supplier to Pfizer Inc., received approval from the U.S. Food and Drug Administration for its naproxen sodium painkiller, the generic version of Bayer AG’s Aleve, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{ARBP IN <Equity> CN <GO>} Link to Company News:{BAYN GR <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at

To contact the editor responsible for this story: Niveditha Ravi at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.